
### [NCIT:C3174](http://purl.obolibrary.org/obo/NCIT_C3174)
**Label:** Chronic Myelogenous Leukemia, BCR-ABL1 Positive

**Subclasses:** [NCIT:C7303](http://purl.obolibrary.org/obo/NCIT_C7303) (Splenic Manifestation of Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C9129](http://purl.obolibrary.org/obo/NCIT_C9129) (Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia), [NCIT:C9070](http://purl.obolibrary.org/obo/NCIT_C9070) (Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C3173](http://purl.obolibrary.org/obo/NCIT_C3173) (Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C9128](http://purl.obolibrary.org/obo/NCIT_C9128) (Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia), [NCIT:C7885](http://purl.obolibrary.org/obo/NCIT_C7885) (Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C3175](http://purl.obolibrary.org/obo/NCIT_C3175) (Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C9110](http://purl.obolibrary.org/obo/NCIT_C9110) (Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C7320](http://purl.obolibrary.org/obo/NCIT_C7320) (Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive), 

**Class expressions from DL-Learner:**

- [NCIT:C36341](http://purl.obolibrary.org/obo/NCIT_C36341) (Signal Transduction Pathway Deregulation) 56.45%
- Thing 55.66%
- [NCIT:C38347](http://purl.obolibrary.org/obo/NCIT_C38347) (P13K-AKT Pathway Deregulation) 51.61%
- [NCIT:C38346](http://purl.obolibrary.org/obo/NCIT_C38346) (MYC Pathway Deregulation) 51.61%
- [NCIT:C38345](http://purl.obolibrary.org/obo/NCIT_C38345) (JUN Pathway Deregulation) 51.61%
- [NCIT:C38344](http://purl.obolibrary.org/obo/NCIT_C38344) (RAS-RAF Pathway Deregulation) 51.61%
- [NCIT:C38343](http://purl.obolibrary.org/obo/NCIT_C38343) (JAK-STAT Pathway Deregulation) 51.61%
- Error9 51.61%
- Error3 51.61%
- [NCIT:C36340](http://purl.obolibrary.org/obo/NCIT_C36340) (Molecular Pathway Deregulation) and (not ([NCIT:C36339](http://purl.obolibrary.org/obo/NCIT_C36339) (Cell Cycle Deregulation))) 47.59%
- [NCIT:C36340](http://purl.obolibrary.org/obo/NCIT_C36340) (Molecular Pathway Deregulation) 45.33%
- [NCIT:C36340](http://purl.obolibrary.org/obo/NCIT_C36340) (Molecular Pathway Deregulation) and (not ([NCIT:C38649](http://purl.obolibrary.org/obo/NCIT_C38649) (Vacuolated Plasma Cells in the Bone Marrow))) 45.33%
- [NCIT:C36340](http://purl.obolibrary.org/obo/NCIT_C36340) (Molecular Pathway Deregulation) and (not ([NCIT:C38648](http://purl.obolibrary.org/obo/NCIT_C38648) (Negative Bone Marrow and Peripheral Blood))) 45.33%
- [NCIT:C36340](http://purl.obolibrary.org/obo/NCIT_C36340) (Molecular Pathway Deregulation) and (not ([NCIT:C38647](http://purl.obolibrary.org/obo/NCIT_C38647) (Prolymphocytes Exceed 55 Percent of Lymphoid Cells in the Peripheral Blood))) 45.33%
- [NCIT:C36340](http://purl.obolibrary.org/obo/NCIT_C36340) (Molecular Pathway Deregulation) and (not ([NCIT:C38646](http://purl.obolibrary.org/obo/NCIT_C38646) (Fried-Egg Appearance of the Bone Marrow))) 45.33%


